We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Monkeypox Virus Can Be Detected in Saliva, Semen and Other Clinical Samples

By LabMedica International staff writers
Posted on 15 Jul 2022

The current monkeypox outbreak represents another zoonotic disease that has crossed borders. More...

In the last six months, more than 9000 cases of monkeypox have been reported worldwide in countries where the disease is not endemic. Initial cases were detected in Britain, Portugal and Spain, mainly in men who have sex with men. However, the disease has spread to many other countries and there is concern that it may spread to vulnerable populations, such as immunocompromised patients or children. The disease is known to be transmitted by direct contact with the lesions of an infected patient or by surfaces contaminated by these lesions, but little is known about the possible presence of virus in other biological samples, such as saliva, urine or semen. Now, a new study has confirmed that viral DNA can be frequently detected in different clinical samples from monkeypox-infected patients, including saliva and semen.

In the study led by the Barcelona Institute for Global Health (ISGlobal; Barcelona, Spain), researchers investigated the presence of genetic material of the virus in different biological samples, collected at different times, from 12 patients with confirmed monkeypox infection. At the time of diagnosis, a high viral DNA load was detected in the skin lesions of all patients. In addition, DNA was detected in the saliva of all cases, some of them with high viral loads. Only one previous study had tested saliva, in one single patient. Viral DNA was also detected in rectal (11 of 12 patients), nasopharyngeal (10/12 patients), semen (7/9 patients), urine (9/12 patients) and fecal (8/12 patients) samples.

The study contributes to a better understanding of how this emerging disease is transmitted. The researchers have pointed out that the presence of viral DNA does not necessarily mean infectious virus, and that the next step will be to try to isolate infectious virus from such samples. However, the high viral load detected in saliva or semen suggests that such fluids have infectious potential, according to the researchers.

"A couple of previous studies had already shown occasional presence of viral DNA in some samples and in some patients, but here we show that viral DNA is frequently present in various biological fluids, particularly saliva, during the acute phase of the disease, and up to 16 days after the onset of symptoms in one patient," said Aida Peiró, first author of the study.

"The results of our study contribute to a better understanding of the mechanisms and dynamics of virus transmission, as well as the possible role of sexual transmission," concluded Mikel Martinez, ISGlobal researcher.

Related Links:
ISGlobal 


Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.